medigraphic.com

2020, Number 1

<< Back Next >>

Cuba y Salud 2020; 15 (1)

Adjuvant substances and adjuvant-induced inflammatory autoimmune syndrome. Case presentation

Tamayo CAM, Orozco JMA, Posada RDA

Language: Spanish
References: 13
Page: 59-64
PDF size: 1461.85 Kb.


ABSTRACT

Human beings need to preserve and improve their bodies´ self-image in a fast and efficient way, without scars leads them to consult non-qualified staff, in search of facial or body fillings with modeling substances miscalled biopolymers; non-suitable for the use in the human body causing posterior complications. The clinical case presented, refers to a 42-year-old women, to whom liquid silicone was injected in the gluteal area and mouth lips; 2 years after the infiltration, started presenting local clinical manifestations around the area of injection such as increased volume, induration and fever, motivating the patient to consult. Protocolary studies were carried out by the multidisciplinary medical team who diagnosed gluteal allogenosis with local and systemic migration of the modeling substance, deep right femoral venous thrombosis, tubule interstitial nephritis with chronic kidney failure stage 4, altogether converging into the diagnose of autoimmune inflammatory syndrome induced by adjuvants (ASIA).


REFERENCES

  1. Ortíz Monasterio F. Management of patients with complications from injections of foreign materials into the breast. Rev Plast. Reconstr. Surg. 1972;50(1):42-7.

  2. Torres Gómez B. Enfermedad por la infiltración de sustancias modelantes con fines estéticos. Rev Cir Plast. 2010; 20(3): 124-32.

  3. Juárez E, Amezcua MC. Hallazgos en resonancia magnética y asociación entre el inicio de los síntomas de pacientes con enfermedad por modelantes en región glútea y el agente químico empleado. Rev Anales de Rad. 2013; 12(4):223-30.

  4. A Juárez. Enfermedad humana por adyuvante en el embarazo. Clin Invest Gin Obst. 2013;40(6):277-8.

  5. Torres Gómez B. Enfermedad por la infiltración de sustancias modelantes con fines estéticos. Rev Cir Plast. 2010;20(3):105-111.

  6. Caldeira M, Caldeira A. Siliconosis: autoimmune /inflamatory syndrome induced by adjuvants (ASIA). ISR Med Assoc J. 2012;14(2):137-8

  7. Tishler M, Schoenfeld Y. Vaccinationmay be associated with autoimmune diseases. Isr Med Assoc J. 2004;6(7):430-2.

  8. Schoenfeld Y, Agmon –Levin N. Autoimmune/inflammatory syndrome induced by adjuvants. J. Autoinmmun. 2011;36(1):4-8.

  9. Alijotas-Reig J. Human adjuvant-related syndrome or autoimmune/inflammatory syndrome induced by adjuvants. Where have we come from? Where are we going? A proposal for new diagnostic criteria. Lupus. 2015;24(10):1012-8. PubMed:PMID:25813870.

  10. Torres Ruiz JJ, Martín-Nares E. Síndrome Autoinmune/inflamatorio inducido por adyuvantes (ASIA). Rev Medica [Internet]. 2016 [citado8 Feb 2019];7(3):170-81. Disponible en: https://www.medigraphic.com/pdfs/revmed/md-2016/md163j.pdf.

  11. Coiffman F. Alogenosis iatrogénica. Una nueva enfermedad. En: Coiffman F. Vásquez G. Cirugía plástica, reconstructiva y estética. ed 3ra. Colombia: Amolca; 2007. p.207-13.

  12. Coiffman F. Alogenosis iatrogénica. Una nueva enfermedad. Cir Plast Iberolatinoam. 2008;34(1):1-10.

  13. Zimmermann U, Clerici T. The histological aspects of fillers fomplications. Semin Cutan Med Surg. 2004;23:241-50.




2020     |     www.medigraphic.com